<DOC>
	<DOC>NCT00171236</DOC>
	<brief_summary>The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia</brief_summary>
	<brief_title>Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>1016 years old Heterozygous familial hypercholesterolemia Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study Other protocol defined inclusion and exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Heterozygous familial hypercholesterolemia</keyword>
	<keyword>mixed dyslipidemia</keyword>
</DOC>